For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240325:nRSY2082Ia&default-theme=true
RNS Number : 2082I Transense Technologies PLC 25 March 2024
25 March 2024
Transense Technologies plc
("Transense" or "the Company")
Transaction in own shares
Change to Total Voting Rights
Transense Technologies plc, the provider of specialist sensor technology and
measurement systems, announces that on 22 March 2024, the Company purchased
70,000 of its own ordinary shares of 10p each ("Ordinary Shares") at a price
of 100 pence per share. These shares will be held in treasury for the time
being to satisfy share option awards in the future.
Following these transactions, the total number of Ordinary Shares held as
treasury shares by the Company is 1,152,856. The total number of Ordinary
Shares in issue (including shares held as treasury shares) is 16,437,740.
Therefore, the total number of voting rights in the Company is 15,284,884
which may be used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their interest in, or
a change to their interest in the Company under the FCA's Disclosure Guidance
and Transparency Rules.
In accordance with Article 5(1)(b) of the UK version of Regulation (EU) No.
596/2014 which is part of UK law by virtue of the European Union (Withdrawal)
Act 2018, the information below contains information about the purchases made
by Shard Capital Stockbrokers on behalf of the Company as part of the buyback
programme.
Aggregate information:
Shares purchased: Transense Technologies plc (ISIN CODE: GB00BDHDTH21)
Date of purchases: 22 March 2024
Investment firm Shard Capital Stockbrokers
Venue London Stock Exchange
Number of ordinary shares purchased 70,000
Volume-weighted average price, pence 100
Highest price paid (per ordinary share), pence 100
Lowest price paid (per ordinary share), pence 100
For further information please visit www.transense.com or contact:
Transense Technologies plc Via Walbrook PR
Nigel Rogers (Executive Chairman)
Melvyn Segal (CFO)
Allenby Capital (Nominated Adviser and Broker) Tel: +44 (0)20 3328 5656
Jeremy Porter / George Payne (Corporate Finance)
Stefano Aquilino / Tony Quirke (Sales & Corporate Broking)
Walbrook PR Tel: +44 (0)20 7933 8780
Tom Cooper/Nick Rome / Joseph Walker Transense@walbrookpr.com
Notes to Editors:
Transense is a developer of specialist sensor technology and measurement
systems. The Company has two active business divisions:
· Translogik a range of smart, connected tyre inspection and management
equipment, used by leading tyre manufacturers, dealers and fleet operators to
reduce costs and improve safety; and
· SAWsense, developing Surface Acoustic Wave (SAW) sensor technology,
to improve performance, reliability and efficiency in focus markets of
aerospace, automotive, robotics and industrial machinery.
In addition, the Company earns residual royalty income from Bridgestone iTrack
(new branding name for iTrack), a tyre condition and performance monitoring
system, that was developed by Translogik and subsequently licensed to
Bridgestone Corporation for a ten year period in 2020, expiring in 2030.
The Group's strategy is to maximise shareholder value through the delivery of
sustained revenue growth from its business divisions by leveraging excellence
in innovation and know-how to commercialise technologies through industry
partnerships and exposure to global growth markets.
Transense is headquartered in Oxfordshire, UK, and was admitted to trading on
AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999.
www.transense.com
For further information please contact transense@walbrookpr.com
(mailto:transense@walbrookpr.com)
Schedule of Purchases - Individual Transactions
Number of Shares Price Per Share (pence) Trading Venue Date of Transaction Time of transaction
70,000 100 London Stock Exchange 22 March 2024 14:47:58
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSEASDSADLLEFA